AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 71 min read$ARQQ

Ritchie Garth sold $3K of ARQQ

Ritchie Garth sold 127 shares of Arqit Quantum Inc. (ARQQ) at $23.78 on 2026-10-05.

Original reporting
SEC EDGAR · Ritchie Garth
Published Oct 7, 2026, 11:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 11:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ARQQ
Neutral
high confidence
Mentioned
$ARQQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQQNeutralLow
01

Why it matters

The sale is too small to affect price materially, but it adds to the transparency record.

02

Market read

Routine insider sale with negligible market impact.

03

What to watch

Potential upcoming dilution or secondary offering not disclosed.

Relevance 3/10Novelty 3/10Timing: post-filing today

Background

Form 4 filings disclose insider transactions; this one reports a director's modest sale.

Company-level read

Ticker impact

$ARQQNeutralHigh confidence
Context

Director Ritchie Garth sold 127 shares of Arqit Quantum for $3,020.66 in a Form 4 filing.

Expected impact

likely slight downward pressure as the market prices the insider sell

Evidence & confidence

The transaction size ($3K) is trivial relative to market cap; no broader implications.

Market effects

Sector

minimal impact on quantum/defense sector

Regional

none

Global

none

Counterpoint

What could challenge this read

Even small insider sales can signal concerns; watch for further disposals.

Key entities

  • company
    Arqit Quantum Inc.

    US-listed quantum communications firm (NASDAQ: ARQQ).

  • person
    Ritchie Garth

    Director of Arqit Quantum.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ARQQ insider trading history →

Related articles

JUN 4
$QNTMedAI 9/10

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.

finance.yahoo.com4 min
OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min